Insiders · Profile

Avalon Ventures XI, L.P.

10% owner at Janux Therapeutics. Filing since 15 Jun 2021. CIK 0001652901

Company
Date
Role
Action
Shares
Amount
Of holding
18 Oct 2024
10% owner
Sold at will
801,751
$36.69M
66.6%
18 Oct 2024
10% owner
Sold at will
660,018
$30.21M
24.2%
17 Oct 2024
10% owner
Sold at will
1,843
$92.19K
22.4%
16 Oct 2024
10% owner
Sold at will
108,906
$5.44M
17.1%
16 Oct 2024
10% owner
Sold at will
100,610
$5.04M
94.0%
30 Sep 2024
10% owner
Sold at will
958
$44.30K
12.2%
27 Sep 2024
10% owner
Sold at will
57,590
$2.68M
9.5%
27 Sep 2024
10% owner
Sold at will
49,231
$2.29M
87.7%
26 Sep 2024
10% owner
Sold at will
109,700
$5.18M
16.5%
26 Sep 2024
10% owner
Sold at will
90,300
$4.26M
3.1%
12 Sep 2024
10% owner
Sold at will
191,969
$9.02M
25.1%
12 Sep 2024
10% owner
Sold at will
158,031
$7.43M
5.1%
10 Sep 2024
10% owner
Sold at will
55,446
$2.58M
8.4%
10 Sep 2024
10% owner
Sold at will
45,645
$2.12M
1.4%
9 Sep 2024
10% owner
Sold at will
2,182
$92.36K
23.8%
6 Sep 2024
10% owner
Sold at will
131,635
$5.53M
17.7%
6 Sep 2024
10% owner
Sold at will
108,365
$4.55M
3.3%
3 Jun 2024
10% owner
Sold at will
822,721
$45.04M
56.5%
3 Jun 2024
10% owner
Sold at will
677,279
$37.08M
17.2%
13 Nov 2023
10% owner
Bought
849,854
$4.99M
opened
15 Jun 2021
10% owner
Bought
629,411
$10.70M
16.3%
21 decisions on file.